Skip to main content
. 2021 Feb 9;36(11):2084–2093. doi: 10.1093/ndt/gfaa332

Table 1.

Characteristics of the study cohort overall and by UF rate at baseline

Patient characteristics Overall (N = 15 414) UF rate ≤13 mL/h/kga
(n = 14 065)
UF rate >13 mL/h/kga (n = 1312)
Demographics
Age (years), mean ± SD 76.3 ± 6.3 76.3 ± 6.3 76.4 ± 6.3
Female, n (%) 7838 (50.8) 7054 (50.2) 763 (58.2)
Race, n (%)
 White 10 626 (68.9) 9715 (69.1) 881 (67.1)
 Black 4063 (26.4) 3745 (26.6) 312 (23.8)
 Asian 477 (3.1) 382 (2.7) 94 (7.2)
 Native American 91 (0.6) 80 (0.6) 11 (0.8)
 Other/unknown 157 (1.0) 143 (1.0) 14 (1.1)
Hispanic ethnicity, n (%) 1237 (8.0) 1097 (7.8) 136 (10.4)
 Missing 48 (0.3) 46 (0.3) 2 (0.2)
Dual Medicare/Medicaid eligible, n (%) 4151 (26.9) 3718 (26.4) 421 (32.1)
Catheter vascular access, n (%) 9732 (63.1) 8900 (63.3) 808 (61.6)
 Missing 37 (0.2) 57 (0.4) 3 (0.3)
Census data
Unemployed, median (IQR) 9.3 (6.8–12.4) 9.3 (6.8–12.4) 9.5 (7.0–12.7)
 Missing, n (%) 140 (0.9) 129 (0.9) 11 (0.8)
Below poverty line, median (IQR) 13.9 (8.3–20.9) 13.8 (8.2–20.8) 15.0 (8.7–22.0)
 Missing, n (%) 141 (0.9) 130 (0.9) 11 (0.8)
Less than a high school education, median (IQR) 14.0 (8.8–21.1) 13.9 (8.8–21.0) 15.1 (9.2–22.4)
 Missing, n (%) 140 (0.9) 129 (0.9) 11 (0.8)
Monthly rent (US$), median (IQR) 859 (686–1069) 857 (685–1065) 874 (692–1105)
 Missing, n (%) 312 (2.0) 282 (2.0) 30 (2.3)
Annual household income (US$), median (IQR) 48 125 (38 245–63 555) 48 151 (38 397–63 653) 47 639 (37 132–63 010)
 Missing, n (%) 144 (0.9) 132 (0.9) 12 (0.9)
Hospital days in the 30 days prior to UF rate ascertainment, mean ± SD 0.9 ± 3.0 0.9 ± 2.9 1.2 ± 3.5
Comorbid medical conditions, n (%)
Coronary artery disease 8547 (55.4) 7781 (55.3) 747 (56.9)
Myocardial infarction 2110 (13.7) 1886 (13.4) 216 (16.5)
Unstable angina 2598 (16.9) 2351 (16.7) 239 (18.2)
Heart failure 9540 (61.9) 8575 (61.0) 942 (71.8)
Coronary revascularization 3337 (21.6) 3058 (21.7) 271 (20.7)
ICD or pacemaker 950 (6.2) 869 (6.2) 80 (6.1)
Ventricular fibrillation or another arrhythmia 2405 (15.6) 2153 (15.3) 245 (18.7)
Valvular heart disease 4580 (29.7) 4067 (28.9) 498 (38.0)
Stroke or TIA 2873 (18.6) 2613 (18.6) 243 (18.5)
Hypertension 15276 (99.1) 13 938 (99.1) 1301 (99.2)
Peripheral artery disease 5685 (36.9) 5141 (36.6) 525 (40.0)
Diabetes mellitus 10 523 (68.3) 9613 (68.3) 884 (67.4)
Hyperlipidemia 11 468 (74.4) 10 512 (74.7) 930 (70.9)
Liver disease 1136 (7.4) 996 (7.1) 136 (10.4)
Chronic lung disease 5889 (38.2) 5317 (37.8) 554 (42.2)
Depression 2392 (15.5) 2148 (15.3) 234 (17.8)
Biometric measurements
eGFR at HD initiation (mL/min/1.73 m2), mean ± SD 10.4 ± 4.4 10.4 ± 4.3 10.6 ± 4.5
 Missing, n (%) 162 (1.1%) 147 (1.0%) 14 (1.1%)
HD treatments in the 30-day UF rate ascertainment period, mean ± SD 12.3 ± 1.6 12.3 ± 1.6 12.2 ± 1.7
Delivered UF rate (mL/h/kg)a, mean ± SD 7.7 ± 4.0 7.0 ± 3.2 15.6 ± 2.8
Predialysis systolic BP (mmHg), mean ± SD 147.3 ± 19.7 147.1 ± 19.6 148.7 ± 20.0
 Missing, n (%) 170 (1.1) 142 (1.0) 20 (1.5)
Delivered treatment time (min), mean ± SD 208.7 ± 24.5 209.8 ± 24.3 196.5 ± 23.4
UF volume (L), mean ± SD 1.9 ± 1.0 1.8 ± 0.9 3.0 ± 0.7
Postdialysis weight (kg), mean ± SD 73.3 ± 17.9 74.5 ± 17.9 60.2 ± 12.3
Interdialytic weight gain (kg), mean ± SD 2.0 ± 1.2 1.9 ± 1.2 3.1 ± 1.1
Prescribed ‘dry’ weight (kg), mean ± SD 73.3 ± 18.0 74.6 ± 17.9 59.7 ± 12.2
Body mass index (kg/m2), mean ± SD 27.7 ± 7.0 28.1 ± 7.0 24.0 ± 5.3
Predialysis diastolic BP (mmHg), mean ± SD 72.3 ± 10.1 72.3 ± 10.0 72.5 ± 10.6
 Missing, n (%) 170 (1.1) 142 (1.0) 20 (1.5)
Serum albumin (g/L), mean ± SD 3.6 ± 0.5 3.6 ± 0.4 3.6 ± 0.5
 Missing, n (%) 161 (1.0) 141 (1.0) 18 (1.4)
Serum potassium (mEq/L), mean ± SD 4.5 ± 0.6 4.4 ± 0.6 4.6 ± 0.7
 Missing, n (%) 169 (1.1) 148 (1.1) 18 (1.4)
Calcium (mg/L), mean ± SD 8.9 ± 0.7 9.0 ± 0.7 8.8 ± 0.7
 Missing, n (%) 149 (1.0%) 130 (0.9%) 17 (1.3%)
a

Thirty-seven patients who were missing delivered UF rate (due to missing treatment time, UF volume or postdialysis weight) at baseline were excluded.

TIA, transient ischemic attack.